Cargando…

Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer()

PURPOSE: Gastric cancer studies indicated a potential correlation between circulating tumor cells (CTCs) in peripheral blood and tumor relapse/metastasis. The prevalence and significance of circulating tumor microemboli (CTM) in gastric cancer remain unknown. We investigated the prevalence and progn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Xiumei, Fan, Li, Zhou, Pengfei, Ma, Hong, Huang, Shaoyi, Yu, Dandan, Zhao, Lei, Yang, Shengli, Liu, Jun, Huang, Ai, Cai, Congli, Dai, Xiaomeng, Zhang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406582/ https://www.ncbi.nlm.nih.gov/pubmed/28448959 http://dx.doi.org/10.1016/j.tranon.2017.02.007

Ejemplares similares

Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy
por: Zhang, Dejun, et al.
Publicado: (2017)

Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer
por: Chen, Yang, et al.
Publicado: (2021)

Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions
por: Mascalchi, Mario, et al.
Publicado: (2017)

New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma
por: Wan, Shanshan, et al.
Publicado: (2019)

Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection
por: Chen, Jia-Yang, et al.
Publicado: (2016)

EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli
por: Song, Shouyang, et al.
Publicado: (2022)

CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor
por: Torres, Jacqueline Aparecida, et al.
Publicado: (2023)

Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
por: Silvestri, Marco, et al.
Publicado: (2021)

Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9
por: Chu, Hsueh-Yao, et al.
Publicado: (2021)

A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer
por: Abdallah, Emne Ali, et al.
Publicado: (2020)

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness
por: Long, Elodie, et al.
Publicado: (2016)

Detection and cultivation of circulating tumor cells in gastric cancer
por: Kolostova, Katarina, et al.
Publicado: (2015)

Detection of Circulating Tumor Cells
por: de Wit, Sanne, et al.
Publicado: (2014)

Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers
por: Suzuki, Takeyuki, et al.
Publicado: (2020)

Detection of circulating stage III–IV gastric cancer tumor cells based on isolation by size of epithelial tumor: using the circulating tumor cell biopsy technology
por: Lu, Rong, et al.
Publicado: (2019)

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer
por: Jie, Xiao-Xiang, et al.
Publicado: (2022)

Electrochemical Biosensors for Circulating Tumor DNA Detection
por: Wang, Ke, et al.
Publicado: (2022)

Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer
por: Ning, Dawei, et al.
Publicado: (2021)

Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis
por: Tang, Lanhua, et al.
Publicado: (2013)

Detection of circulating tumor cells in patients with pituitary tumors
por: Hua, Gao, et al.
Publicado: (2018)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022)

Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells
por: Lin, Peter Ping, et al.
Publicado: (2017)

Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer
por: Zhang, Hongyi, et al.
Publicado: (2021)

Circulating tumor cells in the early detection of human cancers
por: Feng, Zixin, et al.
Publicado: (2022)

Clinical Application of Circulating Tumor Cells in Gastric Cancer
por: Lee, Moon Won, et al.
Publicado: (2019)

Emerging Role of Circulating Tumor Cells in Gastric Cancer
por: Thanh Huong, Phung, et al.
Publicado: (2020)

Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer
por: Paschold, Lisa, et al.
Publicado: (2022)

Oesophagus cancer, secondary cardiac tumour, and pulmonary microemboli
por: Tanaka, Yutaka, et al.
Publicado: (2022)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)

Postoperative circulating tumor DNA detection and CBLB mutations are prognostic biomarkers for gastric cancer
por: Zhou, Hekai, et al.
Publicado: (2023)

Combined detection of aneuploid circulating tumor‐derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non‐small‐cell lung cancer
por: Lei, Yuanyuan, et al.
Publicado: (2020)

Prognostic Role of the Circulating Tumor Cells Detected by Cytological Methods in Gastric Cancer: A Meta-Analysis
por: Zou, Kun, et al.
Publicado: (2016)

Nanotechnology for the detection and kill of circulating tumor cells
por: Gao, Yang, et al.
Publicado: (2014)

The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

Detection of circulating tumor DNA in patients with osteosarcoma
por: Barris, David M., et al.
Publicado: (2018)

Circulating Tumor DNA as Biomarkers for Cancer Detection
por: Han, Xiao, et al.
Publicado: (2017)

Application of Microfluidics in Detection of Circulating Tumor Cells
por: Li, Can, et al.
Publicado: (2022)

Detection of circulating tumor cells: opportunities and challenges
por: Ju, Siwei, et al.
Publicado: (2022)

Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer
por: Li, Yilin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4cvcf2jorhbpd972q2gf1nq4ql